Industry experts gather to discuss the current investor market and how the IRA may impact the industry in the coming years.
US Pharma and Biotech Summit 2024: The View from Investors
You May Also Like
Global Launch Strategies in the Current Political Climate
February 19, 2025
FDA Approves Samsung Bioepis Biosimilars Ospomyv and Xbryk
February 19, 2025
Navigating Distrust: Pharma in the Age of Social Media
February 18, 2025
+ There are no comments
Add yours